Mersana Therapeutics, Inc. (MRSN) Total Assets by Year
Mersana Therapeutics, Inc. closed fiscal year 2024 with $144.7M in total assets, $154.2M in total liabilities and -$9.5M in shareholder equity. This represents a decrease of 36.0% from the prior fiscal year. The table below carries 10 fiscal years, from 2015 to 2024, and the quarters Mersana Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
MRSN Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $144.7M-36.0% | $226.1M-32.4% | $334.3M+62.2% | $206.1M-24.6% | $273.4M+154.2% | $107.5M+37.0% | $78.5M-39.9% | $130.7M+24.4% | $105.1M | N/A |
| Total Liabilities | $154.2M-18.5% | $189.2M-21.9% | $242.3M+187.2% | $84.4M+86.2% | $45.3M+55.1% | $29.2M-58.1% | $69.7M+14.8% | $60.7M-62.2% | $160.7M | N/A |
| Total Equity | -$9.5M-125.8% | $36.9M-59.9% | $92.1M-24.4% | $121.7M-46.6% | $228.1M+191.2% | $78.3M+790.5% | $8.8M-87.4% | $70.0M+225.8% | -$55.6M-30.3% | -$42.7M |
MRSN Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $62.7M-63.0% | $84.6M-52.8% | $112.5M-43.3% | $144.7M-36.0% | $169.5M-35.5% | $179.1M-42.4% | $198.4M-33.0% | $226.1M-32.4% | $262.9M-16.5% | $311.0M+23.2% | $296.2M+14.7% | $334.3M+62.2% |
| Total Liabilities | $122.2M-27.5% | $137.7M-19.3% | $143.3M-15.9% | $154.2M-18.5% | $168.5M-20.0% | $170.7M-22.8% | $170.4M-26.5% | $189.2M-21.9% | $210.7M-6.2% | $221.2M+87.0% | $231.9M+97.0% | $242.3M+187.2% |
| Total Equity | -$59.5M-5775.6% | -$53.1M-730.7% | -$30.9M-210.3% | -$9.5M-125.8% | $1.0M-98.0% | $8.4M-90.6% | $28.0M-56.5% | $36.9M-59.9% | $52.2M-42.2% | $89.8M-33.0% | $64.3M-54.2% | $92.1M-24.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Mersana Therapeutics, Inc. financials
Frequently Asked Questions
What was Mersana Therapeutics, Inc.'s total assets in fiscal year 2024?
Mersana Therapeutics, Inc. closed fiscal year 2024 with $144.7M in total assets, $154.2M in total liabilities and -$9.5M in shareholder equity.
How fast is Mersana Therapeutics, Inc.'s total assets growing?
Mersana Therapeutics, Inc. (MRSN) total assets fell by 36.0% year over year, from $226.1M to $144.7M in fiscal year 2024.
What was Mersana Therapeutics, Inc.'s total assets in the most recent quarter?
Mersana Therapeutics, Inc. (MRSN) reported $62.7M in total assets in Q3 2025. This represents a decrease of 63.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Mersana Therapeutics, Inc. (MRSN) reported on that line in every period on record.